Some mornings the mirror catches me off guard. I know this might sound strange, especially when one is new to caregiving. But I haven’t just…
Myeloma
Adults in the U.S. now have a new generic drug option — Bortezomib for Injection, an equivalent of the approved medication Velcade (bortezomib) —…
Before I got multiple myeloma, I didn’t think much about health insurance. I didn’t even have health insurance 40 years ago! I was young…
Every morning usually starts the same way now. First, I warm the water for my mum’s tea. I prepare it exactly the way she likes…
Tecvayli (teclistamab) extended survival and kept disease under control longer than standard treatments in patients with relapsed or refractory multiple myeloma, meaning the…
About 20 years ago, I worked seven days a week at two different jobs. My weekday job was an hour north of my home, while…
At 2:17 a.m., the house is completely still. No sounds can be heard anywhere at this time of night. I lie on the couch with…
The European Commission has approved a new subcutaneous (under-the-skin) formulation of Sarclisa (isatuximab), a treatment for multiple myeloma that was previously available in…
I catch glimpses of him in the bathroom mirror at 3 a.m. He is thinner than I remember. His eyes look older, even though the…
Treatment with a regimen based on the experimental therapy mezigdomide reduced the risk of disease progression or death by more than 50% compared with standard…
Recent Posts
- Infection risk shifts over time with both CAR T and bispecific antibody therapy
- Building the quiet architecture of a caregiving day
- New CAR T-cell therapy shows promise in tough myeloma cases
- CAR T-cell therapy before surgery boosts glioblastoma control in mice
- Gynecologic Cancer Awareness Month urges education, action, and support